Your browser doesn't support javascript.
loading
Serum Visfatin/NAMPT as a Potential Risk Predictor for Malignancy of Adrenal Tumors.
Sawicka-Gutaj, Nadia; Komarowska, Hanna; Gruszczynski, Dawid; Derwich, Aleksandra; Klimont, Anna; Ruchala, Marek.
Affiliation
  • Sawicka-Gutaj N; Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, 60-355 Poznan, Poland.
  • Komarowska H; Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, 60-355 Poznan, Poland.
  • Gruszczynski D; Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, 60-355 Poznan, Poland.
  • Derwich A; Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, 60-355 Poznan, Poland.
  • Klimont A; Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, 60-355 Poznan, Poland.
  • Ruchala M; Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, 60-355 Poznan, Poland.
J Clin Med ; 11(19)2022 Sep 22.
Article in En | MEDLINE | ID: mdl-36233428
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: J Clin Med Year: 2022 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: J Clin Med Year: 2022 Document type: Article Affiliation country: